ロード中...
CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
Brain atrophy and altered CSF levels of amyloid β (Aβ(42)) and the microtubule-associated protein tau are potent biomarkers of Alzheimer's disease (AD)-related pathology. However, the relationship between CSF biomarkers and brain morphometry is poorly understood. Thus, we addressed the followin...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society for Neuroscience
2010
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2828879/ https://ncbi.nlm.nih.gov/pubmed/20147537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.3785-09.2010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|